SYK — Stryker Corporation stock price and chart

SYK

Stryker CorporationStock · HealthcareS&P 500 Equal Weight 0.2% · S&P 500 0.2% · Russell 1000 0.2% · US Stock Market 0.2% · Russell 3000 0.1% · MSCI World 0.1% · MSCI ACWI 0.1%

$275.56+2.06%

as of market close, Sep 11, 2026

☾ AH — —

PeersMRNALLYUNHJNJMRKABBV

Technical analysis2

Overlay lines0

Addendum charts0

VolumeDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDD

20162019202120242026

150.0200.0250.0300.0350.0400.0010.0M20.0M$275.56

2026-09-11

Price$275.56

MA20$317.71

MA50$349.20

Vol24.1M

What would $1,000 invested in SYK be worth today? →

SYK returns: By year · By month · By week · Trailing

Key stats

Price data

Price: $275.56
Change YTD: -21.18%
Next earnings: Oct 29, 2026
Market cap: 105.7B2016-09 43.6B2026-09 105.7B+142.4% over the window
Enterprise value: 117.8B
Shares outstanding: 383.6M2016-06 374.3M2026-06 383.6M+2.5% over the window
52W low: $267.00
52W high: $392.55
From 52W high: -29.80%
From 52W low: +3.21%
52W range: 7%
Beta: 0.76

Volume

Rel volume: 1.40×
30D volume: 2.7M
30D $ vol: 842.8M

Fundamentals

Sales (ttm): 25.8B2016-06 10.5B2026-06 25.8B+146.8% over the window
Sales/share: $67.362016-06 $27.972026-06 $67.36+140.8% over the window
EPS (ttm): $9.652016-06 $4.242026-06 $9.65+127.6% over the window
FCF (ttm): 4.7B2016-06 614M2026-06 4.7B+665.8% over the window
FCF/share: $12.262016-06 $1.642026-06 $12.26+647.3% over the window
Book value/share: $62.542016-06 $24.312026-06 $62.54+157.3% over the window
Net margin: 14.43%2016-06 15.3%2026-06 14.4%-5.8% over the window
ROE: 15.55%2016-06 17.6%2026-06 15.5%-11.9% over the window
ROA: 7.78%2016-06 7.8%2026-06 7.8%-0.5% over the window
Debt / equity: 0.59×2016-06 0.742026-06 0.59-19.9% over the window
Current ratio: 2.162016-06 2.172026-06 2.16-0.6% over the window

Growth (CAGR, ttm) · 10Y

Sales: +8.48%2025-06-30 → 2026-06-3023.8B → 25.8B (+8.5% total)+9.92%2023-06-30 → 2026-06-3019.5B → 25.8B (+32.8% total)+9.72%2021-06-30 → 2026-06-3016.2B → 25.8B (+59.0% total)+9.45%2016-06-30 → 2026-06-3010.5B → 25.8B (+146.8% total)
Net income: +27.81%2025-06-30 → 2026-06-302.9B → 3.7B (+27.8% total)+11.24%2023-06-30 → 2026-06-302.7B → 3.7B (+37.7% total)+12.35%2021-06-30 → 2026-06-302.1B → 3.7B (+79.0% total)+8.80%2016-06-30 → 2026-06-301.6B → 3.7B (+132.3% total)
FCF: +16.86%2025-06-30 → 2026-06-304B → 4.7B (+16.8% total)+24.83%2023-06-30 → 2026-06-302.4B → 4.7B (+94.5% total)+9.60%2021-06-30 → 2026-06-303B → 4.7B (+58.2% total)+22.58%2016-06-30 → 2026-06-30614M → 4.7B (+665.8% total)
Shares: +0.33%2025-06-30 → 2026-06-30382.3M → 383.6M (+0.3% total)+0.33%2023-06-30 → 2026-06-30379.8M → 383.6M (+1.0% total)+0.34%2021-06-30 → 2026-06-30377.1M → 383.6M (+1.7% total)+0.25%2016-06-30 → 2026-06-30374.3M → 383.6M (+2.5% total)

Per-share growth (CAGR, ttm) · 10Y

EPS: +27.84%2025-06-30 → 2026-06-30$7.55 → $9.65 (+27.8% total)+10.87%2023-06-30 → 2026-06-30$7.08 → $9.65 (+36.3% total)+12.07%2021-06-30 → 2026-06-30$5.46 → $9.65 (+76.7% total)+8.57%2016-06-30 → 2026-06-30$4.24 → $9.65 (+127.6% total)
Sales/share: +8.12%2025-06-30 → 2026-06-30$62.30 → $67.36 (+8.1% total)+9.55%2023-06-30 → 2026-06-30$51.23 → $67.36 (+31.5% total)+9.35%2021-06-30 → 2026-06-30$43.08 → $67.36 (+56.4% total)+9.19%2016-06-30 → 2026-06-30$27.97 → $67.36 (+140.8% total)
FCF/share: +16.48%2025-06-30 → 2026-06-30$10.53 → $12.26 (+16.5% total)+24.42%2023-06-30 → 2026-06-30$6.36 → $12.26 (+92.6% total)+9.23%2021-06-30 → 2026-06-30$7.88 → $12.26 (+55.5% total)+22.28%2016-06-30 → 2026-06-30$1.64 → $12.26 (+647.3% total)
Book value/share: +12.83%2025-06-30 → 2026-06-30$55.43 → $62.54 (+12.8% total)+11.01%2023-06-30 → 2026-06-30$45.71 → $62.54 (+36.8% total)+11.28%2021-06-30 → 2026-06-30$36.65 → $62.54 (+70.6% total)+9.91%2016-06-30 → 2026-06-30$24.31 → $62.54 (+157.3% total)
Dividend/share: +4.82%2025-06-30 → 2026-06-30$3.32 → $3.48 (+4.8% total)+5.72%2023-06-30 → 2026-06-30$2.95 → $3.48 (+18.2% total)+7.14%2021-06-30 → 2026-06-30$2.47 → $3.48 (+41.2% total)+8.89%2016-06-30 → 2026-06-30$1.48 → $3.48 (+134.3% total)
Price: -29.14%2025-09-11 → 2026-09-11$388.79 → $275.56 (-29.1% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-2.76%2023-09-11 → 2026-09-11$299.72 → $275.56 (-8.1% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+0.12%2021-09-10 → 2026-09-11$273.86 → $275.56 (+0.6% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+9.56%2016-09-09 → 2026-09-11$110.54 → $275.56 (+149.3% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.
Total return: -28.42%2025-09-11 → 2026-09-11$384.87 → $275.56 (-28.4% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-1.81%2023-09-11 → 2026-09-11$291.08 → $275.56 (-5.3% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+1.17%2021-09-10 → 2026-09-11$260.00 → $275.56 (+6.0% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+10.78%2016-09-09 → 2026-09-11$98.98 → $275.56 (+178.4% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.: 28.6×2016-09 26.272026-09 28.34+7.8% over the window
P/OI (ttm)Price ÷ TTM operating income. Excludes the below-the-line items that make P/E jump — mark-to-market gains, settlements, tax true-ups.: 19.1×2016-09 20.252026-09 19.09-5.7% over the window
Fwd P/E: 18.1×
P/S (ttm)Market cap ÷ TTM revenue.: 4.1×2016-09 4.012026-09 4.09+2.1% over the window
P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.: 4.4×2016-09 4.672026-09 4.40-5.7% over the window
P/FCF (ttm)Market cap ÷ TTM free cash flow (operating cash flow − capex).: 22.5×2016-09 27.522026-09 22.47-18.3% over the window
EV/EBITDA (fy): 16.5×
EV/Sales (ttm): 4.6×
FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.: 4.45%2016-06 1.4%2026-06 3.9%+177.3% over the window
Dividend yield (fwd)Indicated forward annual dividend ÷ current price — the rate the company has announced, not what was actually paid over the past year.: 1.26%
Dividend/share (fwd): $3.48
Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 383.6M ÷ 382.3M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.: -0.33%
Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (-0.33%) + dividends paid over that year ($1.3B) ÷ market_cap_at(2025-06-30) ($151.3B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.: 0.54%
Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($0) ÷ today's market cap ($105.7B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.: 0.00%2016-06 0.9%2026-06 0.0%-100.0% over the window
Shareholder yield (cash, ttm)(TTM buybacks net of issuance $0 + TTM dividends $1.3B) ÷ today's market cap ($105.7B). Same caveat as the cash buyback yield.: 1.25%2016-06 2.1%2026-06 1.1%-48.9% over the window

Vs own 10Y history

P/E: 15th
P/OI: 0th
P/S: 4th
P/B: 1st
P/FCF: 0th

Bar = where today’s multiple sits in SYK’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · windows as of 2026-09-11

+2.06%

-10.53%

-20.64%

-9.60%

YTD

-21.18%

-27.31%

+4.53%

Financial statements

Open full SYK financials →

Loading financial statements…

Ticker	Name	1M	1D
LLY	Eli Lilly and Company	-8.44%	-0.65%
JNJ	Johnson & Johnson	+2.31%	-0.29%
ABBV	AbbVie Inc.	+3.36%	+0.83%
MRK	Merck & Co. Inc.	+8.28%	-0.54%
UNH	UnitedHealth Group Incorporated Common Stock (DE)	-6.53%	-2.37%
TMO	Thermo Fisher Scientific Inc.	+1.13%	+1.10%
AMGN	Amgen Inc.	-8.80%	-1.34%
GILD	Gilead Sciences Inc.	+5.78%	-0.75%

Stryker Corporation (SYK) trades at $275.56 with a live price and an interactive chart covering 45+ years of daily price history, plus key valuation metrics. ChartRow also publishes SYK’s financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full SYK financial statements →

SYK — Stryker Corporation price, chart and key statistics